During the past decade, WellSpan Health-York Cancer Center conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 59 clinical trials were completed, i.e. on average, 74.7% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 30 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WellSpan Health-York Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "Radiation Therapy Oncology Group" with 32 trials sponsored, "SWOG Cancer Research Network" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored and "NSABP Foundation Inc" with 18 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WellSpan Health-York Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 107 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "WellSpan Health-York Cancer Center" are "Breast Cancer" (19 trials), "Lung Cancer" (11 trials), "Prostate Cancer" (10 trials), "Stage IV Lung Cancer AJCC v8" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (9 trials). Many other conditions were trialed in "WellSpan Health-York Cancer Center" in a lesser frequency.

Most popular intervention types in "WellSpan Health-York Cancer Center" are "Drug" (115 trials), "Other" (69 trials), "Radiation" (56 trials), "Biological" (46 trials) and "Procedure" (39 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Quality-of-Life Assessment" (27 trials), "radiation therapy" (19 trials), "Biospecimen Collection" (16 trials) and "Computed Tomography" (15 trials). Other intervention names were less common.

The vast majority of trials in "WellSpan Health-York Cancer Center" are 109 trials for "All" genders, 32 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "WellSpan Health-York Cancer Center". undefined are not yet recruiting, 28 are recruiting, 56 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in WellSpan Health-York Cancer Center, 3 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in WellSpan Health-York Cancer Center, 3 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 100 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".